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Abstract
Background: A key to increasing the power of multilocus association tests is to reduce the
number of degrees of freedom by suppressing noise from data. One of the difficulties is to decide
how much noise to suppress. An often overlooked problem is that commonly used association
tests based on genotype data cannot utilize the genetic information contained in spatial ordering of
SNPs (see proof in the Appendix), which may prevent them from achieving higher power.
Results:  We develop a score test based on wavelet transform with empirical Bayesian
thresholding. Extensive simulation studies are carried out under various LD structures as well as
using HapMap data from many different chromosomes for both qualitative and quantitative traits.
Simulation results show that the proposed test automatically adjusts the level of noise suppression
according to LD structures, and it is able to consistently achieve higher or similar powers than
many commonly used association tests including the principle component regression method
(PCReg).
Conclusion: The wavelet-based score test automatically suppresses the right amount of noise and
uses the information contained in spatial ordering of SNPs to achieve higher power.
Background
In a genome-wide association study (GWAS), if a SNP has
a strong LD with a disease locus, single marker methods
should have more power than multiple marker methods.
However, if several SNPs have moderate associations with
disease genes, multiple marker methods (such as Hotel-
ling's T2 test [1-4] or multiple logistic regression) can pro-
vide higher power [5]. One of the problems of multiple
marker methods is their large number of degrees of free-
dom, which in turn may lead to low power. Therefore,
reducing the number of degrees of freedom becomes a key
issue in gaining power for a multilocus method. For exam-
ple, in haplotype association studies, tests based on hap-
lotype sharing [6,7] have fewer degrees of freedom and
higher power than tests based on haplotype frequencies.
Another common approach to reducing the number of
degrees of freedom is PCReg [8,9]. Projections of geno-
type data onto a few principal component directions of
the variance-covariance matrix can often capture a major-
ity of genotypic variances, and have fewer degrees of free-
dom. Tests based on projected genotype data can
potentially have higher power. A weighted score test based
on the Fourier transform [10] was also introduced to
reduce the number of degrees of freedom. The basic idea
behind this test is to transform genotype data into Fourier
coefficients, and form the test based on those Fourier coef-
ficients. Noise reduction is done by putting high weights
on low frequency components, and low weights on high
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frequency components. The rationale behind this
approach is a belief that assuming the signal function
belongs to a certain smoothness class, high frequency
components are mostly noise and therefore should be
suppressed. This method works well if genotypic variation
is across all SNPs. Under the common disease and rare
variant hypothesis, a collapsing method and a combined
multivariate and collapsing method were proposed [11],
in which the genotypes of rare variants are collapsed to
reduce the number of degrees of freedom and to increase
power.
Reducing the number of degrees of freedom in genetic
studies is similar to suppressing noisy data; the difficulty
is to know how much of the data should be suppressed. A
good test should adapt to LD structures, which means it
can automatically decide the amount of noise to be sup-
pressed. In a window of SNPs, if most of the SNPs are not
associated with the disease, then most genotypic varia-
tions are noise, which should all be suppressed. On the
other hand, if most of the SNPs are in fact associated with
the disease, then these genotypic variations are true sig-
nals and therefore should be kept. An ideal noise suppres-
sion (de-noising) process should automatically choose an
optimal suppression level to maximize the signal to noise
ratio. We propose a novel test, which is able to automati-
cally choose an optimal suppression level.
Many tests based on genotype data, for example, Hotel-
ling's T2 test [1-4], logistic regression test and PCReg [8],
do not take the spatial order of the SNPs on a chromo-
some into consideration (see proof in the Appendix). As a
result, interchanging the relative positions of two SNPs
does not have an effect on the tests (see proof in the
Appendix). The test we proposed in this paper takes the
order of the SNPs on a chromosome into consideration,
and it gains power by doing so. Tests based on haplotype
data also consider the order of SNPs on a chromosome.
For example, the ordering of SNPs is essential for tests
based on haplotype similarity (the longest continuous
interval of matching alleles between haplotypes). If the
relative order of SNPs is changed, the shared length
between two haplotypes will be reduced and the disease
association cannot be detected. If we assume affected indi-
viduals share some ancestral haplotypes, the relative posi-
tions of SNPs on a chromosome contain genetic
information associated with a disease, and ignoring this
information may reduce the power of genetic association
tests. The proposed test is a compromise between these
genotype-based and haplotype-based tests in the sense
that the ordering of SNPs is considered but ambiguous
haplotypes do not need to be inferred.
Results and Discussion
Wavelet transform
Wavelet transformation is a method for decomposing
data into different frequency components. It is an effective
noise suppressing (de-noising) method, and it is designed
to deal with choppy signals. Because of its adaptability to
jumps, small wiggles, and other unusual features in the
target function, it has become an important tool to replace
the Fourier transform in many practical situations. The
introduction of the wavelet method in statistics began
more than a decade ago [12]. Since then it has been
applied to many areas of statistics including nonparamet-
ric regression, time series analysis, nonparametric density
estimation, and contingency table cell probability estima-
tion [13].
Dilation and translation of a pair of father and mother
wavelets {φ, ψ} generates an orthonormal wavelet basis
for the space of square-integrable functions. A square-inte-
grable function f(x) can be written as a wavelet series:
where ci, j are the wavelet coefficients and φi, j and ψi, j are
the wavelet basis functions. A discrete wavelet transform
changes discrete data to wavelet coefficients. There are
many choices for the father and mother wavelets, and they
are chosen to give the wavelet transformation desired
properties: to suppress noise more effectively; to be easily
adapted to dense or sparse signals, and to deal with uns-
mooth functions with unusual features. Noise suppres-
sion is achieved by removing terms from the above
summation (letting some wavelet coefficients be zero),
while the main features of the target function can still be
kept. Computing discrete wavelet coefficients is faster
than computing Fourier coefficients. The time required for
calculating discrete wavelet coefficients of n data points is
O(n), and that for Fourier coefficients is O(n log n).
There are three steps in a wavelet transformation. Step one
is to transform genotype scores to wavelet coefficients.
Step two decides which wavelet coefficients to be removed
or shrunk, and this process is called thresholding. Step
three transforms the modified wavelet coefficients back to
modified genotype scores. The key to reducing the
number of degrees of freedom and increasing the power
lies in step two: thresholding. A wavelet coefficient is kept
if it is greater than a high threshold, it is dropped if it is
smaller than a low threshold, and it is shrunk if it lies in
between the two thresholds. For a data set, one can choose
a single threshold for all wavelet coefficients, or choose
multiple thresholds to handle wavelet coefficients on dif-
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ferent resolution levels and with different frequencies.
One can also choose thresholds manually. But this will
not work for a GWAS. The scale of a GWAS calls for a data-
dependent choice of thresholds. The simplest data-
dependent threshold is a universal single threshold [12],
which is given by  , where σ is the standard
deviation of noise and n is the sample size. It is generally
believed that at high resolution levels the wavelet coeffi-
cients of the signal are more sparse than those in the low
resolution levels, therefore, a level-dependent choice of
thresholds is better than the universal threshold. A false
discovery rate (FDR) method has been used in choosing
level-dependent thresholds [14]. While it works well for
sparse signals, it does not adapt very well to dense signals.
Many other thresholding methods have been proposed,
and this is still an active research area.
We chose the empirical Bayesian thresholding [15]. The
advantages of this approach include its superior adapta-
bility to sparse and dense signals. It is a data-dependent,
automatic procedure. Let Ci = μi + i be the sample wavelet
coefficients at a certain resolution level, where i represents
noise. Suppose the signal μi has a prior distribution (1 -
w)δ0 + wγ, where δ0 is an atom probability at zero and γ is
a unimodal symmetric density. Let  (c, w) be the median
of the posterior distribution of μ, given C = c. There exists
t(w) such that  (c, w) = 0 if and only if |c| ≤ t(w). If   is
the marginal maximum likelihood estimator of w, then
the empirical Bayesian threshold is t() .
After thresholding wavelet coefficients of genotype scores,
we apply inverse wavelet transformation to obtain modi-
fied genotype scores. A score test is formed based on those
modified genotype scores. The three step procedure of
wavelet transformation is illustrated in Figure 1, where a
genotype score of an individual is transformed into wave-
let coefficients, which are then thresholded and trans-
formed back to modified genotype scores.
tn = σ 2log( ) ˆ μ
ˆ μ ˆ w
ˆ w
Before and after wavelet transform Figure 1
Before and after wavelet transform. The process of transforming original genotype data to its wavelet coefficients, thresh-
olding the wavelet coefficients, and obtaining the modified genotype data by inverse transform of the thresholded wavelet coef-
ficients.
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Wavelet-based score test
Consider a sample of n independent individuals geno-
typed at m SNPs, and let X = (Xij) be a matrix of genotypes,
where Xij is the coded genotype of the ith individual at the
jth SNP according to additive, recessive, or dominant dis-
ease models. For a given window, SNPs are recoded to
maximize the number of positive pairwise correlation
among them. For an additive model, at each SNP, one
homozygous genotype is coded as 0, the other
homozygous genotype is coded as 2, and the hetero-
zygous genotype is coded as 1. This yields a sample geno-
type matrix. If at some SNPs, the coding of two
homozygous genotypes is interchanged, a different sam-
ple genotype matrix will be obtained. Among all possible
different sample genotype matrices, we choose the one
that has the maximum number of positive entries in its
sample variance-covariance matrix. This is done individu-
ally for each set of SNPs. This coding is always unique
when applied to real data and it removes any ambiguity in
the coding of genotypes. In our simulation studies, this
recoding process did not inflate the type I error rate. Let Y
= (Yi) be the trait value vector, where Yi is the trait value of
the ith individual. The values Yi can represent qualitative
or quantitative traits. For a case-control design, Yi = 1 for
affected individuals and Yi = 0 for unaffected individuals.
We assume the trait values and genotypes are related by a
generalized linear model [16]
where f is the link function and Xi = (Xi1, Xi2,..., Xim). We
first find the wavelet coefficients of Xi. We then threshold
the wavelet coefficients using empirical Bayesian thresh-
olding. Finally, we apply inverse wavelet transform to the
thresholded wavelet coefficients to obtain the modified
genotype scores, xij. This is done for every individual. If
two individuals have the same genotypes, then they will
have the same modified genotypes as well. A score statistic
is formed as follows. Let
The sample variance of Uj is
The score test statistic is defined as
The empirical p-values are calculated by permutations.
The permutation approach may have limitations for
GWAS. However, when we applied this method to a data
of about 2,000 individuals with 500,000 SNPs, it took less
than a week to run on a cluster with 23 nodes and 65
CPUs, which is still manageable.
Simulations
For a case-control design, we compare the proposed score
test based on wavelet transform (Tw) with the following
commonly used tests: the score test based on Fourier
transform (Tf); a test obtained by fitting a regression func-
tion with one SNP, followed by Bonferroni correction to
find the global p-value (Tb); and a likelihood-ratio test
based on logistic regression (Tl). For quantitative traits, we
compare Tw with Tf, Tb, and PCReg [8] (Tp). The reasons for
choosing these tests to be compared with the proposed
test are the following: we chose Tf because both Tw and Tf
are affected by the order of the SNPs, but we want to show
that Tw adapts better to sparse and dense data than Tf; we
chose Tb because it is a common and very effective test
when one SNP has a strong association with the disease. If
several SNPs have small to moderate information, a
regression with multiple SNPs may have advantages,
which is the reason behind our choice of Tl. Both Tb and Tl
are not affected by the order of SNPs, and they do not sup-
press data to reduce the degrees of freedom. The strength
of Tp lies on data suppression. A comparison of Tw with Tf,
Tb,  Tl, and Tp  demonstrated that Tw  achieves a higher
power by effectively suppressing noise and by using extra
information regarding the ordering of the SNPs.
Case-control design
The type I error rates and the powers of Tw, Tf, Tb, and Tl
were analyzed. In our simulation study, there are 200
cases and 200 controls, and the number of SNPs is m + 1
with the SNP at the center being an unobserved disease
SNP. The allele frequencies of m non-disease SNPs are
obtained from a uniform distribution between 0.2 and
0.8, and the allele frequency of the disease SNP is p. The
haplotypes of the m + 1 SNPs are generated from a multi-
variate normal distribution with a variance-covariance
matrix (ρij). The m + 1 allele frequencies give the cutoff
points, which translate a multivariate normal vector to a
haplotype. The sum of two haplotypes is a genotype vec-
tor. We can only observe the genotype data of cases and
controls on m SNPs; the genotype of the disease SNP is
not observable.
One of the objectives of our simulation studies was to test
the adaptability of the proposed test. To this end, we con-
sidered six LD structure models. In the first three models,
all SNPs were associated with the unobserved disease
locus and they were also associated with each other in var-
ious ways. In the other three models, half of the SNPs were
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related to neither the disease locus nor to each other, and
the other half of the SNPs were related to the disease locus
and also to each other in ways similar to the first three
models. Variance-covariance matrices of the multivariate
normal distribution were used to generate different LD
structures. We used six matrices A1-A6. For i ≠ j, matrices
A1 is given by ρij = 0.4; A2 is given by ρij = 0.8|i-j|; A3 is
given by ρij ~ Unif(0.3, 0.7); A4 is given by ρij = 0.4 if 1 +
 ≤ i, j ≤ 1 +  , and ρij = 0 otherwise; A5 is given by ρij
= 0.8|i-j| if 1 +   ≤ i, j ≤ 1 +  , and ρij = 0 otherwise; A6
is given by ρij ~ Unif(0.3, 0.7) if 1 +   ≤ i, j ≤ 1 +  , and
ρij  = 0 otherwise. Matrices A4-A6 represent situations
where the first and last quarters of SNPs are related to nei-
ther the disease nor other SNPs, and they are purely noise.
To demonstrate the LD structures in these six scenarios,
we generated a simulated sample population of size
10,000 for each scenario, and calculated pairwise D'. The
results are shown in Figure 2. The trait value was generated
from the genotype of the disease SNP according to a mul-
tiplicative model and a relative risk (RR). To check the
type I error rate (when RR = 1) and power, we let RR = 1,
1.15, 1.25, 1.5, 2, 2.5, m = 8 and the disease allele fre-
quency p = 0.4. For each of the six models, the simulation
was repeated 1,000 times, and the proportion with a p
value less than 0.05 was recorded.
HapMap data
Next we applied the wavelet-based test to three genes:
CHI3L2, IL21R, and CTLA4, which have also been ana-
lyzed in other simulation studies [8,10,17]. We down-
loaded genotype data of 60 individuals (parents) from
CEPH (Utah residents with ancestry from northern and
western Europe) in the HapMap [18]. In the following
selections, we only chose SNPs with missing genotypes
less than 5%.
In a 20 kb region around CHI3L2, we chose SNPs with
minor allele frequencies greater than 0.26. This leads to 17
SNPs (rs755467, rs2255089, rs2494004, rs1325284,
rs2251715, rs961364, rs2251608, rs2764543, rs2477574,
rs2477578, rs942694, rs942693, rs2182114, rs5003369,
rs3934922, rs3934923, and rs8535). During simulation
studies, we randomly picked one SNP as the disease locus,
and assumed it was not observed. We sampled a genotype
at the disease locus from 60 individuals, and assigned its
trait value (0 or 1) according to its genotype using a mul-
tiplicative disease model. A sample of 200 cases and 200
controls was then obtained. Next we generated genotypes
of each case and control at the other 16 SNPs by sampling
from individuals with the same genotype at the disease
locus. Suppose we only observed genotype data at these
16 loci. If the disease SNP was among the observed SNPs,
m
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LD patterns Figure 2
LD patterns. Pairwise D' for models with six different LD structures.BMC Genetics 2009, 10:53 http://www.biomedcentral.com/1471-2156/10/53
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single locus methods should have higher power than mul-
tilocus methods. The proposed test is not intended to
replace single locus methods under this situation. We
only claim that the new test has a higher power when
none of the SNPs in the window has a strong association
with the disease by itself, in which case single locus
method may fail to detect signals. In a region of 20 kb
around IL21R, we chose SNPs with minor allele frequen-
cies greater than 0.25. This yields 21 SNPs, in which we
chose the largest block containing nine SNPs (rs179766,
rs7203086, rs2040790, rs11074861, rs7199138,
rs8057551, rs8061992, rs9930086, and rs8049804). A
similar data set as before was generated from these nine
SNPs.
In a region of 200 kb around CTLA4, there are 84 SNPs
with minor allele frequencies greater than 0.25. These 84
SNPs cover eight blocks. Some of the SNPs are highly cor-
related (correlation is 1 for several SNPs). We took nine
tagging SNPs chosen by Haploview [19], which captured
78 of the 84 alleles with a mean r2 of 0.943 (rs2882969,
rs11571293, rs1427680, rs231727, rs6705593,
rs17268364, rs4355090, rs10183087, and rs3096747). A
data set was generated from these nine SNPs in a similar
fashion as before. Power comparisons were also done for
12 sites on chromosomes 1-10, 17, and 22, which have
been studied before [17]. The genotype data of 60 parents
from CEPH population in the HapMap [18] were used to
generate samples as described before. We chose nine SNPs
at each site with minor allele frequencies greater than 0.2.
A SNP is randomly selected as the causal locus which is
removed from the sample, and it varies during the simu-
lation. The observed data consists of genotypes of 200
cases and 200 controls at eight SNPs. The locations of the
12 sites are given in Table 1.
Quantitative traits
The new test can also be applied to quantitative traits. We
compared the power and the type I error rates of Tw with
three commonly used tests Tf, Tb, and Tp. The model used
to generate trait values is y = μ(x1 + βx2) + e, where e is a
standard normal random variable; x1 = 1, 0, -1 and x2 = 0,
1, 0 for genotypes DD, Dd, dd, respectively; and β = -1, 0,
1 for recessive, additive, and dominant models, respec-
tively. We calculated μ from the heritability, which ranges
from 4% to 10%.
PCReg [8] is described as follows. Let G be the matrix of
genotypes, and let y be the vector of trait values. Suppose
y and the columns of G are all centered such that their
means are zeros. Let the columns of A be the first several
characteristic vectors of GTG such that they can explain
more than 80% of the total variation in G. Let G1 = GA be
the projections of the genotype data onto these principal
directions. The regression model is y = G1b1 + , and Tp is the
regression F -statistic. We used permutation to calculate
the empirical p-value of Tp.
Results
In Table 2, the results show that the wavelet-based test Tw
has the correct type I error rates.
Power comparisons under the six LD structures described
before are given in Figure 3. From Figure 3 we can see that
Tw and Tf have similar powers in models 1-3, and they
both have a higher power than Tb and Tl. For models 4-6,
Tw still has the highest power among the four tests, but Tf
is not as good as the other two tests. The wavelet-based
test always has the highest power regardless of whether
the window of SNPs contains SNPs unrelated to the dis-
ease. The wavelet-based test Tw is robust with respect to the
noise level (SNPs unrelated to the disease). When all SNPs
in a window are related to the disease, the wavelet-based
test does not suppress noise too much to lose power, and
when some of the SNPs are unrelated to the disease, it
automatically suppress noise more to reduce the number
of degrees of freedom and to keep its power.
Table 1: Positions of 12 sites on 12 chromosomes.
Positions
Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4
76037376-76046029 165039214-165049745 48194541-48262883 95708105-95724998
Chromosome 5 Chromosome 6 Chromosome 7 Chromosome 8
86318185-86336013 85438224-85448287 79276265-79290697 73096328 -73104287
Chromosome 9 Chromosome 10 Chromosome 17 Chromosome 22
120732024-120745981 67665462-67693578 40283580-40300822 33626551-33661562BMC Genetics 2009, 10:53 http://www.biomedcentral.com/1471-2156/10/53
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Table 2: Type I error rates for tests with qualitative traits.
Type I error rates
LD structures LD = A1 LD = A2 LD = A3 LD = A4 LD = A5 LD = A6
Tw 0.061 0.056 0.039 0.043 0.046 0.050
Tf 0.063 0.059 0.037 0.040 0.035 0.041
Tb 0.055 0.050 0.036 0.054 0.052 0.049
Tl 0.056 0.049 0.046 0.063 0.053 0.060
The window size is eight. Assuming multiplicative disease model. Tw is the wavelet based test, Tf is the Fourier based test, Tb is the single SNP test 
with Bonferroni correction, and Tp is the principal component regression test.
Power comparisons using simulated data Figure 3
Power comparisons using simulated data. Power comparisons of the wavelet-based test (Tw), the Fourier-based test (Tf), 
the single locus test with Bonferroni correction (Tb), and the likelihood-ratio test based on logistic regression (Tl) with eight 
SNPs for a case-control design. The black solid, blue dashed, black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tl, respec-
tively.
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Simulation results for data generated from the HapMap
data on CHI3L2, IL21R, and CTLA4 are given in Figure 4.
In all cases, the score test based on wavelet clearly has the
highest power. For the other three tests, there is no clear
winner. For the 17 SNPs around CHI3L2, the proposed
test has the highest power. The score test based on Fourier
transform is the second when the relative risk is 1.5 or 2,
while the single locus test with Bonferroni correction is
the second when the relative risk is 2.5. For the nine SNPs
on a block around IL21R, the proposed test and the test
based on Fourier transform have similar powers, although
the power of the new test is slightly higher. The powers of
the other two tests are clearly lower. For the nine tagging
SNPs covering eight blocks around CTLA4, the power of
the new test is again the highest under all situations. This
shows that the proposed test has a higher power under
various LD structures.
Note that in the above simulations, the causal locus is ran-
domly chosen among all SNPs around a gene. Therefore,
it is free to vary during simulations. Second, the causal
locus is not observed in any simulations because the
intent of the proposed test is to provide a tool to detect
small to moderate associations in a window of SNPs when
none of them have a strong LD with the disease. We expect
that if the causal locus is observed, the power of single
locus tests will increase more than those of multilocus
tests. Third, the window sizes in our simulations are eight
and 16. When the window size is eight, we can recode gen-
otypes to obtain as many positive pairwise correlations as
possible. For larger window sizes it will not be feasible
because of computational burden. When genotypes are
recoded, it is done for all individuals regardless of their
phenotypes.
The comparison of powers on 12 sites on chromosomes
1-10, 17, 22 are given in Figures 5 and 6 which clearly
demonstrate the superiority in power for the proposed
test.
For quantitative traits, the type I error rates of Tw, Tf, Tb,
and Tp are given in Table 3. Comparisons of the power of
Power comparisons using HapMap data 1 Figure 4
Power comparisons using HapMap data 1. Data sampled from CHI3L2, IL21R, and CTLA4 on HapMap. Power compari-
sons of the wavelet-based test (Tw), the Fourier-based test (Tf), the single locus test with Bonferroni correction (Tb), and the 
likelihood-ratio test based on logistic regression (Tl) for case-control design. The black solid, blue dashed, black dotted, and red 
dot-dash lines are Tw, Tf, Tb, and Tl, respectively.
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these four tests are given in Figures 7, 8, and 9. The results
are similar to those for the qualitative traits, which shows
that Tw has the highest power and correct type I error rate.
Discussion
Simulation studies show that the proposed test achieves a
higher power than other commonly used tests. The
improved power results from three sources. The first is the
use of the wavelet transformation of genotype data. The
wavelet transform is designed to deal with unsmooth sig-
nals with jumps and small wiggles. Genetic data are not
smooth nor periodic, which is naturally dealt with by the
wavelet transform. Using the transformed data instead of
the original data enables us to view the signals in different
frequencies and in different resolution levels separately.
The second is the choice of thresholds in the wavelet
transformation. The wavelet transformation decomposes
data into coefficients corresponding to different frequen-
cies and to different resolution levels. It is generally
believed that a low frequency signal is more likely to be a
true signal than a high frequency one, and a true signal is
more sparse on a fine resolution level than on a coarser
level. Suppressing wavelet coefficients at different fre-
quencies and different resolution levels in various ways
increases the effectiveness of the noise suppression, which
means that the data can be represented by using fewer
wavelet coefficients. Empirical Bayesian thresholding
automatically decides how much noise to be suppressed
at each level according to the data. A wavelet transform
with empirical Bayesian thresholding gives the proposed
test its ability to adapt to LD structures: it suppresses more
if many SNPs under consideration are unrelated with the
disease, and it suppresses less if most SNPs are in fact asso-
ciated with the disease.
The third reason for the improvement of the power comes
from taking the relative positions of SNPs on a chromo-
some into consideration. An important difference
between wavelet-based tests and PCReg is that PCReg does
not consider the relative positions of SNPs. It views a mul-
tilocus genotype as a vector. The wavelet-based test treats
a multilocus genotype as a discretized function instead of
a vector. The difference between regarding genotypes as a
function versus a vector is that viewing it as a function
Power comparisons using HapMap data 2 Figure 5
Power comparisons using HapMap data 2. Data sampled from six sites on chromosomes 1-6 on HapMap. Power com-
parisons of the wavelet-based test (Tw), the Fourier-based test (Tf), the single locus test with Bonferroni correction (Tb), and 
the likelihood-ratio test based on logistic regression (Tl) with eight SNPs for case-control design. The black solid, blue dashed, 
black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tl, respectively.
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allows us to take the order of SNPs on a chromosome into
consideration. The importance of the ordering of SNPs on
a chromosome can be illustrated by the following simple
example. Suppose in a GWAS, one finds two locations. At
one location, multilocus genotype 1#1#1# appears fre-
quently among cases; and at another location ###111
appears often among cases, where # represents noise and
1 represents a heterozygous genotype. The question is
which location is more likely to be a true signal, and
which one is more likely to be noise. For PCReg, the two
locations have the same importance. Projecting onto the
first, the third, and the fifth dimensions is the same as pro-
jecting onto the fourth, the fifth, and the sixth dimen-
sions. However, for a wavelet-based test, they are
Power comparisons using HapMap data 3 Figure 6
Power comparisons using HapMap data 3. Data sampled from six sites on chromosomes 7-10, 17, and 22 on HapMap. 
Power comparisons of thewavelet-based test (Tw), the Fourier-based test (Tf), the single locus test with Bonferroni correction 
(Tb), and the likelihood-ratio test based on logistic regression (Tl) with eight SNPs for case-control design. The black solid, blue 
dashed, black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tl, respectively.
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Table 3: Type I error rates for tests with quantitative traits. 
Type I error rates
LD structures LD = A1 LD = A2 LD = A3 LD = A4 LD = A5 LD = A6
Tw 0.044 0.049 0.050 0.061 0.040 0.047
Tf 0.039 0.040 0.052 0.050 0.025 0.042
Tb 0.036 0.033 0.045 0.041 0.050 0.050
Tp 0.040 0.060 0.037 0.045 0.055 0.051
The window size is eight. Assuming additive disease model. Tw is the wavelet based test, Tf is the Fourier based test, Tb is the single SNP test with 
Bonferroni correction, and Tp is the principal component regression test.BMC Genetics 2009, 10:53 http://www.biomedcentral.com/1471-2156/10/53
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different. A wavelet-based test considers multilocus geno-
types as discretized functions, ###111 represents a low
frequency function, while 1#1#1# represents a high fre-
quency function. If everything else remains the same, a
low frequency function is more likely to be a true signal,
and a high frequency function is more likely to be noise.
It is worth noticing that for tests based on haplotype shar-
ing, ###111 is also more important than 1#1#1# because
the former will increase shared length of haplotypes. In
the Appendix, we prove that many genotype-based tests
and some haplotype-based tests do not utilize the infor-
mation contained in the spatial order of SNPs.
Conclusion
We propose a score test based on a wavelet transforma-
tion. The goal is to increase power by suppressing noise
and therefore reducing the number of degrees of freedom.
The adaptability of the empirical Bayesian thresholding
provides the test with the ability to automatically suppress
the right amount of noise which is shown by simulation
studies using HapMap data. Whether the window con-
tains SNPs related to the disease or not, the proposed test
always has the highest power comparing with the single
marker test with Bonferroni correction and the likelihood-
ratio test based on logistic regression. This shows the effec-
tiveness of the noise suppression by the proposed test. The
second advantage of the proposed test is that it takes the
order of SNPs on a chromosome into consideration. In
this sense, it is a compromise between genotype-based
tests and haplotype-based tests. Since it considers the
order of SNPs, it uses more information than other geno-
type-based methods, while avoiding the need to infer
unobserved haplotypes or their frequencies as in haplo-
type-based tests. Simulation studies show that the pro-
posed test consistently has a higher power than PCReg.
The proposed test and PCReg both suppress data to reduce
the number of degrees of freedom to increase the power.
The major difference between them is that the proposed
test takes the order of SNPs into consideration while
PCReg does not. The difference between their powers
show that considering the order of SNPs does increase the
power of the tests. The proposed test and the test based on
the Fourier transform have similar powers when all SNPs
in a window are related to the disease and the wavelet-
Power comparisons for quantitative traits (dominant) Figure 7
Power comparisons for quantitative traits (dominant). Power comparisons of the wavelet-based test (Tw), the Fourier-
based test (Tf), the single locus test with Bonferroni correction (Tb), and PCReg (Tp) with eight SNPs for quantitative traits. The 
black solid, blue dashed, black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tp, respectively. Assume the dominant disease 
model.BMC Genetics 2009, 10:53 http://www.biomedcentral.com/1471-2156/10/53
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based test has a higher power when some of the SNPs are
not related to the disease. This demonstrates the advan-
tage of using the wavelet transform than using the Fourier
transform. Since genotype data are not smooth nor peri-
odic, it is naturally better dealt with by the wavelet trans-
form. Although the proposed test has many advantages, it
is certainly not universally better than other tests. For
example, if a window contains a SNP strongly associated
with the disease, a single locus method with Bonferroni
correction should be better than any multilocus methods,
including the new test. In a GWAS, researchers usually
apply single locus methods first, and report significant
findings if there are any. Only after that initial step, mul-
tilocus methods are used to identify information missed
by the single locus methods. The proposed test should be
used with this in mind.
If population stratification is a concern, we suggest to
apply EIGENSTRAT [20] to the data to obtain several large
principal components. These principal components are
used to adjust genotypes and phenotypes as suggested by
Price et al. [20]. The wavelet-based test is calculated using
adjusted genotypes and phenotypes. The genomic infla-
tion factor λGC [21] can be used as a criterion to determine
if population structures are present. The new test has been
successfully applied to a GWAS of the North American
Rheumatoid Arthritis Consortium data from Genetic
Analysis Workshop 16 [22].
Web Resource
wavelet-based score test, http://www.math.mtu.edu/
~rjiang/preprint/wavelet.score.test.R
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Power comparisons for quantitative traits (additive) Figure 8
Power comparisons for quantitative traits (additive). Power comparisons of the wavelet-based test (Tw), the Fourier-
based test (Tf), the single locus test with Bonferroni correction (Tb), and PCReg (Tp) with eight SNPs for quantitative traits. The 
black solid, blue dashed, black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tp, respectively. Assume the additive disease 
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Appendix
In the appendix we prove that Tp, the Hotelling's T2 test,
Tb, and Tl are not affected by permuting SNPs. Let G = (gij)
be an n × m genotype matrix, where gij is the genotype of
the ith individual at the jth marker. Subtract the mean of
the jth column from gij such that the mean of each column
of G is 0. The sample covariance matrix of the genotypes
is A = GTG/(n - 1). Suppose that λ1 ≥ λ2≥...≥λm are the
eigenvalues of A, and v1, v2,..., vm are the corresponding
eigenvectors. Let D  be a diagonal matrix with λ1  ≥
λ2≥...≥λm as diagonal entries, and let V be an m × m matrix
with v1, v2,..., vm as columns. Then A = VDV-1. Note that vi
is the ith principal component, i = 1, 2,..., m. Write V =
[V1V2], where V1 contains the used principal components,
and V2 contains the discarded principal components. In
PCReg, the regression model is y = GV1b + .
Suppose the spatial order of SNPs is permuted, then the
columns of G are also permuted accordingly. Suppose the
new genotype matrix is  , then   = GP  where  P  is
obtained from applying the same permutation on the col-
umns of the identity matrix. Assume that   is also cen-
tered so that the mean of each column is 0. Let
. Since P is an orthogonal matrix, PT = P-
1. Therefore,   = PTGTGP = PTVDV-1P = (PTV)D(PTV)-1.
Note that the diagonal matrix of the eigenvalues of   is
still D, and the matrix of eigenvectors of   is PTV. Since A
and   have the same eigenvalues, the used principal
components are the columns of   and the dis-
carded principal components are the columns of
. In PCReg, the regression model after permu-
tation is   which is
the same as before permuting SNPs.
Next, we prove that the Hotelling's T  2 statistic is not
affected by permuting SNPs. Following the notations used  G  G
 G
  AG Gn
T =− /( ) 1
 A
 A
 A
 A
 VP V
T
11 =
 VP V
T
22 =
y G Vb G P P Vb G Vb
T =+ = + =+  
11 1 †† †
Power comparisons for quantitative traits (recessive) Figure 9
Power comparisons for quantitative traits (recessive). Power comparisons of the wavelet-based test (Tw), the Fourier-
based test (Tf), the single locus test with Bonferroni correction (Tb), and PCReg (Tp) with eight SNPs for quantitative traits. The 
black solid, blue dashed, black dotted, and red dot-dash lines are Tw, Tf, Tb, and Tp, respectively. Assume the recessive disease 
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in [3], let X be an n1 × m matrix of genotypes of cases and
let Y be an n2 × m matrix of genotypes of controls, where
n1 is the number of cases, n2 is the number of controls, and
m is the number of SNPs. Let   and   be the column
mean of X and Y, respectively, written as column vectors.
Let Xi and Yi denote the ith row of X and Y, respectively,
written as column vectors. The pooled-sample variance-
covariance matrix of genotypes is
The Hotelling's T2 statistic is
Write ,
where ei is the ith column of the identity matrix, and 1 is
a column vector with every entry being 1. Thus,
where I is the identity matrix and E is a square matrix with
every entry being 1. Therefore,
Suppose the spatial order of SNPs are permuted, the cor-
responding columns of the genotype matrices X and Y are
permuted accordingly. After permutation, let   and   be
the genotype matrix of cases and controls, respectively.
Then   =  XP and   =  YP, where P is a permutation
matrix. The new pooled-sample variance-covariance
matrix is
After permutation,   and   becomes   and  ,
respectively. Recall that P-1 = PT. The Hotelling's T2 statistic
after permuting the spatial order of SNPs is
The same arguments can be applied to prove that the hap-
lotype T2 statistic defined in [3] is not affected by permut-
ing SNPs either. It was proved in [3] that both the
multilocus T2 and the haplotype T2 statistics have the same
power. Usually a haplotype-based test will have a higher,
or at least a different, power than a genotype-based test. It
is a interesting fact that both the multilocus T2 and the
haplotype T2 have the same power and neither have used
the information contained in the spatial order of SNPs.
Recall that Tb is obtained by fitting a regression function
with one SNP, followed by Bonferroni correction to find
the global p-value. Permuting SNPs does not change its
results.
The likelihood-ratio test based on logistic regression Tl is
also not affected by permuting SNPs.
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